Story · Medicine & Biotech
Transcript-based circulating tumor and cancer stem cell detection in inflammatory breast cancer: a six-year prospective evaluation of assay yield and prognostic performance
1 outlet · first reported by Research Square on
Inflammatory breast cancer (IBC) is a rare and aggressive presentation for which no validated blood-based monitoring tool exists, and the tumor emboli that define its biology have motivated interest in circulating tumor cell (CTC) assays. We prospectively evaluated a transcript-based platform… (Research Square)
Coverage, in order
-
Transcript-based circulating tumor and cancer stem cell detection in inflammatory breast cancer: a six-year prospective evaluation of assay yield and prognostic performance
Inflammatory breast cancer (IBC) is a rare and aggressive presentation for which no validated blood-based monitoring tool exists, and the tumor emboli that define its biology have motivated interest in circulating tumor cell (CTC) assays. We prospectively evaluated a transcript-based platform…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.